Clovis Oncology (CLVS) Tops Q3 EPS by 10c
Get Alerts CLVS Hot Sheet
Join SI Premium – FREE
Clovis Oncology (NASDAQ: CLVS) reported Q3 EPS of ($0.89), $0.10 better than the analyst estimate of ($0.99). Revenue for the quarter came in at $38.8 million versus the consensus estimate of $42.64 million.
For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Marpai, Inc. (MRAI) Misses Q2 EPS by 18c
- Eos Energy Enterprises (EOSE) PT Lowered to $5 at B.Riley
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share